FRI0001 Baseline soluble interleukin-6 receptor levels predict the clinical effectiveness of tocilizumab in patients with rheumatoid arthritis
โ Scribed by Nishina, N.; Kikuchi, J.; Hashizume, M.; Yoshimoto, K.; Kameda, H.; Takeuchi, T.
- Book ID
- 125488714
- Publisher
- BMJ Publishing Group
- Year
- 2013
- Tongue
- English
- Weight
- 386 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0003-4967
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In a previous study, we used an enzyme-linked immunosorbent assay to measure soluble human interleukin-2 receptors (IL3R), and found that when activated lymphocytes produce cell-associated IL-2R, they also release a soluble form of IL3R into culture supernatants in vitro. Soluble IL-2R have also bee
Soluble interleukin-2 receptor (sll-2R) levels were quantitated in the seum and synovial fluid (SF) of patients with rheumatoid arthritis (RA) and degenerative joint disease (DJD). A sandwich immunoassay, employing two monoclonal antiodies against distinct epitopes on the lL-2R, was utilized for mea